Clinical Trials for Myelodysplastic Syndrome

1 Open Trial

Trial TypeProtocol No. &
Open Date
Supportive CareVICCBMT1218
A Randomized, Prospective, Double Blind, Placebo-Controlled, Phase 3 Study of US-ATG-F Prophylaxis as a Supplement to Standard of Care Prophylaxis to Prevent Moderate to Severe Chronic GVHD in Adult Acute Myeloid Leukemia, Acute Lymphoid Leukemia, and Myelodysplastic Syndrome Patients after Allogeneic Stem Cell Transplantation from Unrelated Donors

You do not have JavaScript enabled. This site works better with JavaScript turned on.